Affinage

RHO

Rhodopsin · UniProt P08100

Audit flag: wrong gene
Length
348 aa
Mass
38.9 kDa
Annotated
2026-06-14
40 papers in source corpus 14 papers cited in narrative 14 extracted findings
Cross-family judge vs UniProt: tie

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

Rhodopsin is the heptahelical G-protein-coupled receptor of rod photoreceptors that converts photon absorption into visual signaling (PMID:11495733). Its seven-transmembrane bundle covalently binds 11-cis-retinal via a Schiff base within an extracellularly-open binding cavity closed intracellularly by the tilted helix 3 and stabilized by a disulfide bridge (PMID:9775210, PMID:11495733); photon capture drives ultrafast (sub-200 fs), vibrationally coherent cis-trans isomerization of the chromophore, the primary photochemical event facilitated by the protein environment (PMID:11743865). Isomerization propagates through light-induced transmembrane helical rearrangements (PMID:26140679) to form the active state, which is recognized by the C-terminal region of the transducin alpha subunit; this interaction stabilizes the active receptor conformation (PMID:1782650). Signaling is terminated in two steps: rhodopsin kinase binds the cytoplasmic loops of photoactivated rhodopsin (notably the V-VI loop) and phosphorylates C-terminal serines/threonines sequentially, Ser-338 first then Ser-343 and Thr-336 (PMID:2071581, PMID:7662865), with phosphorylation initiating deactivation and arrestin binding completing it (PMID:9775212); arrestin binding additionally facilitates subsequent in vivo dephosphorylation of rhodopsin (PMID:35332081). Kinase activity is held in check by Ca2+-bound recoverin, which forms a membrane-associated complex with rhodopsin kinase to suppress phosphorylation (PMID:8617359). Beyond signaling, reconstituted rhodopsin acts as an ATP-independent phospholipid scramblase, accelerating transbilayer phospholipid translocation over 1000-fold (PMID:26179029). Misfolded and constitutively active mutants link rhodopsin to retinal degeneration: lysine ubiquitylation drives turnover of P23H misfolded rhodopsin (PMID:37440077), and the constitutively active K296E mutant aggregates and mislocalizes in photoreceptors in a species-dependent manner (PMID:40667763).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 1991 High

    Established how the deactivation machinery and the G protein engage the activated receptor, defining the cytoplasmic surface as the recognition hub for both rhodopsin kinase and transducin.

    Evidence C-terminal/cytoplasmic-loop truncation plus kinase activity assays, and synthetic transducin alpha C-terminal peptide binding with 2D NMR on Metarhodopsin II

    PMID:1782650 PMID:2071581

    Open questions at the time
    • Full-length kinase-receptor and Gt-receptor complex structures not resolved here
    • Stoichiometry and kinetics of competing kinase vs Gt binding unresolved
  2. 1995 High

    Resolved the order and limit of C-terminal phosphorylation, showing deactivation is encoded by site-specific, sequential phosphate addition capped by arrestin.

    Evidence Mass spectrometry of phosphopeptides and biochemical phosphorylation assays

    PMID:7662865

    Open questions at the time
    • Functional consequence of each individual site for downstream signaling not quantified here
    • In vivo phosphorylation kinetics not addressed
  3. 1996 Medium

    Identified the Ca2+/recoverin brake on deactivation, linking intracellular calcium to suppression of rhodopsin kinase activity.

    Evidence Membrane association and kinase activity assays with recoverin titration in vitro

    PMID:8617359

    Open questions at the time
    • Structural basis of the ternary membrane complex not defined
    • In vivo contribution to light adaptation not tested in this study
  4. 1998 High

    Genetically separated the two deactivation steps in living rods, proving phosphorylation initiates and arrestin completes shutoff of the light response.

    Evidence Transgenic C-terminal truncation and arrestin-knockout mouse rods with single-cell suction electrode electrophysiology

    PMID:9775212

    Open questions at the time
    • Molecular timing of arrestin recruitment relative to phosphorylation not resolved
    • Does not address dephosphorylation/recovery for the next cycle
  5. 1998 High

    Provided the first 3D architecture of rhodopsin, establishing the heptahelical fold distinct from bacteriorhodopsin and the retinal cavity geometry.

    Evidence Electron cryo-microscopy and electron crystallography of 2D crystals at 7.5 Å

    PMID:9775210

    Open questions at the time
    • Resolution insufficient for side-chain detail
    • Active-state conformation not captured
  6. 2001 High

    Defined the primary photochemistry and the high-resolution ground-state structure, anchoring how chromophore isomerization initiates activation in a GPCR scaffold.

    Evidence Femtosecond/picosecond time-resolved spectroscopy with locked retinal analogs, and X-ray crystallography of bovine rhodopsin

    PMID:11495733 PMID:11743865

    Open questions at the time
    • Coupling of femtosecond isomerization to slower helix movements not directly bridged
    • Active Metarhodopsin II structure not solved here
  7. 2015 High

    Demonstrated a non-canonical enzymatic function of rhodopsin as an ATP-independent phospholipid scramblase, and mapped light-induced helix dynamics underlying activation.

    Evidence Reconstitution into unilamellar vesicles with scramblase assay; site-directed spin labeling and EPR/DEER

    PMID:26140679 PMID:26179029

    Open questions at the time
    • Physiological role of scramblase activity in rod membranes not established
    • Structural pathway of lipid translocation not identified
  8. 2018 High

    Revealed an open channel from the retinal pocket to the lipid bilayer and lumen, rationalizing ligand exchange and pharmacological chaperone stabilization of opsin.

    Evidence X-ray crystallography of stabilized opsin at 2.4 Å with thermofluor/virtual screening of stabilizing ligands

    PMID:29555765

    Open questions at the time
    • Whether the channel is the physiological retinal entry/exit route in vivo not proven
    • Therapeutic efficacy of chaperones in disease models not addressed here
  9. 2022 High

    Uncovered an unexpected role for arrestin in promoting rhodopsin dephosphorylation in vivo, extending arrestin's function beyond signal quenching.

    Evidence Arrestin-knockout mice with isoelectric focusing, transducin double-knockout controls, and ARR1-3A binding-competent rescue

    PMID:35332081

    Open questions at the time
    • Identity and recruitment of the responsible phosphatase not defined
    • Mechanism by which arrestin presents phosphosites for dephosphorylation unknown
  10. 2023 Medium

    Showed that lysine ubiquitylation targets misfolded rhodopsin for degradation, defining a quality-control route for disease-associated rhodopsin.

    Evidence HEK293 expression of K-null P23H constructs with ubiquitylation assays and cycloheximide chase

    PMID:37440077

    Open questions at the time
    • E3 ligase and degradation pathway not identified
    • Cell-line system; relevance to photoreceptor degeneration not tested in vivo
  11. 2025 Medium

    Linked the constitutively active K296E mutant to aggregation and mislocalization in photoreceptors, with species-dependent aggregation propensity contributing to retinal degeneration.

    Evidence Knockin mouse models with PROTEOSTAT aggregate staining and in vitro aggregation assays across species backgrounds

    PMID:40667763

    Open questions at the time
    • Molecular determinants of species-specific aggregation not pinpointed
    • Whether aggregation or constitutive signaling is the primary degenerative driver unresolved

Open questions

Synthesis pass · forward-looking unresolved questions
  • How the ultrafast chromophore isomerization is mechanistically coupled to the millisecond helix rearrangements that build the transducin-competent active state, and how quality-control degradation versus aggregation outcomes are decided for mutant rhodopsin, remain open.
  • No structure of the rhodopsin-transducin-kinase signaling/deactivation supercomplex in the timeline
  • Phosphatase mediating arrestin-facilitated dephosphorylation unidentified
  • Physiological function of scramblase activity unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060089 molecular transducer activity 2 GO:0140096 catalytic activity, acting on a protein 2 GO:0140299 molecular sensor activity 2 GO:0008289 lipid binding 1 GO:0016740 transferase activity 1
Localization
GO:0005886 plasma membrane 2
Pathway
R-HSA-162582 Signal Transduction 2 R-HSA-1643685 Disease 2 R-HSA-9709957 Sensory Perception 2

Evidence

Reading pass · 14 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1991 Rhodopsin kinase binds to the cytoplasmic loops of photoactivated rhodopsin (Rho*) — specifically the V-VI loop is crucial for kinase binding (analogous to transducin binding) — and this binding stimulates the kinase's catalytic activity. Phosphorylation by rhodopsin kinase occurs exclusively at C-terminal serine/threonine sites of Rho*. Enzymatic truncation of rhodopsin C-terminus and cytoplasmic loops followed by rhodopsin kinase activity assays with exogenous peptide substrates; mastoparan peptide mimicry experiments The Journal of biological chemistry High 2071581
1991 The C-terminal region of the alpha subunit of transducin (Gt) interacts with photoactivated rhodopsin (Metarhodopsin II) and stabilizes the active conformation of the receptor; synthetic peptides from the alpha-t C-terminus mimic Gt in this interaction. The conformation of such a peptide bound to Metarhodopsin II was determined by 2D NMR, and mutant peptide analogs confirmed the structural model. Synthetic peptide binding assays, 2D NMR of peptide bound to Metarhodopsin II, peptide analog mutagenesis Cellular and molecular neurobiology High 1782650
1995 Rhodopsin kinase phosphorylates photoactivated rhodopsin sequentially at C-terminal sites, with the first phosphate preferentially transferred to Ser-338, then Ser-343 and Thr-336. Arrestin binding to phosphorylated rhodopsin limits physiologically significant phosphorylation to no more than three sites; reduction of all-trans-retinal to all-trans-retinol also limits phosphorylation. Mass spectrometry sequencing of phosphopeptides, biochemical phosphorylation assays with rhodopsin kinase Biophysical chemistry High 7662865
1996 Ca2+-bound recoverin forms a complex with rhodopsin kinase preferentially at the membrane surface, and this membrane-associated ternary complex (Ca2+-recoverin–rhodopsin kinase–membrane) leads to effective suppression of rhodopsin kinase activity, inhibiting light-dependent phosphorylation of rhodopsin. Biochemical membrane association assays, rhodopsin kinase activity measurements with varying membrane concentrations and recoverin FEBS letters Medium 8617359
1998 Removal of rhodopsin's carboxy-terminal phosphorylation sites in transgenic mouse rods prolongs the flash response 20-fold and makes it highly variable; deletion of arrestin results in partial recovery with 100-fold slowed final recovery. These experiments establish that rhodopsin phosphorylation initiates deactivation and arrestin binding completes deactivation. Transgenic mouse models (C-terminal truncation, arrestin knockout), single-cell suction electrode electrophysiology of rod photoreceptors Eye (London, England) High 9775212
1998 Electron cryo-microscopy and electron crystallography of 2D rhodopsin crystals revealed a 7.5 Å resolution 3D map showing seven transmembrane helices with distinct arrangement from bacteriorhodopsin: three helix layers near the intracellular (G protein-interacting) side, a retinal-binding cavity open toward the extracellular side, closed intracellularly by the long tilted helix 3, and closed extracellularly by the loop 4-5 linked by a disulfide bridge to the extracellular end of helix 3. Electron cryo-microscopy, image processing, and electron crystallography of 2D crystals Eye (London, England) High 9775210
2001 Picosecond time-resolved spectroscopy of 11-cis locked rhodopsin analogs established that cis-trans isomerization of the 11-cis retinal chromophore is the primary photochemical reaction in rhodopsin. Femtosecond pump-probe spectroscopy showed formation of photorhodopsin within 200 fs and that the photoisomerization proceeds via a vibrationally coherent process. The protein environment facilitates efficient isomerization relative to retinal in solution. Picosecond time-resolved spectroscopy, femtosecond transient absorption (pump-probe), femtosecond fluorescence spectroscopy, locked retinal analogs Biochemistry. Biokhimiia High 11743865
2001 X-ray crystal structure of bovine rhodopsin revealed the 3D arrangement of the 7-transmembrane helical bundle as a GPCR, showing the 11-cis-retinal chromophore covalently bound via Schiff base in a binding pocket, and demonstrated that rhodopsin's helix arrangement differs from bacteriorhodopsin despite both having heptahelical bundles. X-ray crystallography Current opinion in structural biology High 11495733
2015 When reconstituted into large unilamellar vesicles, rhodopsin functions as an ATP-independent phospholipid scramblase, accelerating transbilayer translocation of common phospholipids by more than 1000-fold to rates exceeding 10,000 phospholipids per rhodopsin per second. Reconstitution of rhodopsin into large unilamellar vesicles, phospholipid scramblase activity assay Photochemical & photobiological sciences High 26179029
2015 EPR spectroscopy with spin labeling identified light-induced transmembrane helical movements in rhodopsin upon photoactivation, characterizing functional loop dynamics, millisecond-timescale conformational changes, effects of partial agonists on opsin, and lipid interactions, establishing the structural basis of GPCR activation. Site-directed spin labeling, EPR spectroscopy, pulsed EPR (DEER/PELDOR) Photochemical & photobiological sciences Medium 26140679
2018 Crystal structure of pharmacologically stabilized opsin at 2.4 Å resolution revealed an open channel connecting the orthosteric retinal binding site with the membrane and the intradiscal lumen, sufficient in size to permit exchange of hydrophobic ligands such as retinal. Small molecule pharmacological chaperones bind at the orthosteric binding site and stabilize the receptor. X-ray crystallography (2.4 Å resolution), virtual and thermofluor screening for stabilizing ligands, chemical modification of stabilizing compounds Proceedings of the National Academy of Sciences of the United States of America High 29555765
2022 Visual arrestin (ARR1) binding to light-activated phosphorylated rhodopsin facilitates rhodopsin dephosphorylation in vivo. In Arr1 knockout mouse rods, rhodopsin remained phosphorylated even after 3 hours in darkness, compared to near-complete dephosphorylation within 1 hour in wild-type. This effect required ARR1 binding competence (ARR1-3A mutant with binding rescued dephosphorylation), and was independent of transducin signaling or protein phosphatase 2A downregulation. Arrestin knockout mice, isoelectric focusing to resolve phosphorylated rhodopsin species, transducin double-knockout controls, ARR1-3A binding-competent mutant rescue The Journal of neuroscience High 35332081
2023 Ubiquitylation of lysine residues on P23H misfolded rhodopsin drives its accelerated protein turnover/degradation. Mutation of all 11 lysine residues to arginine (K-null P23H) significantly reduced ubiquitylation and slowed protein turnover compared to intact P23H rhodopsin. Wild-type rhodopsin with all lysines mutated to arginine also showed significantly reduced ubiquitylation. Transfection of HEK293 cells with K-null P23H rhodopsin constructs, ubiquitylation assays, cycloheximide chase analysis of protein turnover Advances in experimental medicine and biology Medium 37440077
2025 The K296E rhodopsin mutant (constitutively active) mislocalizes and forms protein aggregates in photoreceptor cells in knockin mice, contributing to retinal degeneration. Aggregation propensity of K296E rhodopsin was confirmed in vitro and was dependent on species background: mouse and human rhodopsin backgrounds showed aggregation, while bovine background did not, indicating species-specific differences in aggregation. Knockin mouse generation, PROTEOSTAT dye staining for protein aggregates, in vitro aggregation assays across species backgrounds FASEB journal Medium 40667763

Source papers

Stage 0 corpus · 40 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1991 Mechanism of rhodopsin kinase activation. The Journal of biological chemistry 237 2071581
2001 Photoisomerization in rhodopsin. Biochemistry. Biokhimiia 132 11743865
2013 Molecular complexes that direct rhodopsin transport to primary cilia. Progress in retinal and eye research 130 24135424
2021 Efficient optogenetic silencing of neurotransmitter release with a mosquito rhodopsin. Neuron 115 33979634
2001 Crystal structure of rhodopsin: implications for vision and beyond. Current opinion in structural biology 104 11495733
2022 Rhodopsin, light-sensor of vision. Progress in retinal and eye research 83 36273969
2015 Rhodopsin Trafficking and Mistrafficking: Signals, Molecular Components, and Mechanisms. Progress in molecular biology and translational science 66 26055054
2020 NeoR, a near-infrared absorbing rhodopsin. Nature communications 64 33173168
2012 Structure and activation of rhodopsin. Acta pharmacologica Sinica 62 22266727
2014 Constitutively active rhodopsin and retinal disease. Advances in pharmacology (San Diego, Calif.) 56 24931191
1998 Structure of rhodopsin. Eye (London, England) 56 9775210
2013 Relevance of rhodopsin studies for GPCR activation. Biochimica et biophysica acta 51 24041646
2002 Rhodopsin and retinitis pigmentosa: shedding light on structure and function. Receptors & channels 49 12402507
1998 Control of rhodopsin activity in vision. Eye (London, England) 41 9775212
2009 Rhodopsin-mediated retinitis pigmentosa. Progress in molecular biology and translational science 39 20374723
2015 Phospholipid scrambling by rhodopsin. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 38 26179029
2010 Complexes between photoactivated rhodopsin and transducin: progress and questions. The Biochemical journal 38 20423327
2016 Rhodopsin targeted transcriptional silencing by DNA-binding. eLife 35 26974343
2018 Ligand channel in pharmacologically stabilized rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 32 29555765
2008 Activity switches of rhodopsin. Photochemistry and photobiology 29 18422873
1996 Calcium-bound recoverin targets rhodopsin kinase to membranes to inhibit rhodopsin phosphorylation. FEBS letters 26 8617359
1991 Molecular interactions between the photoreceptor G protein and rhodopsin. Cellular and molecular neurobiology 26 1782650
2020 Rhodopsin: A Potential Biomarker for Neurodegenerative Diseases. Frontiers in neuroscience 24 32351353
1995 Mechanism of rhodopsin phosphorylation. Biophysical chemistry 21 7662865
2019 Rhodopsin Oligomerization and Aggregation. The Journal of membrane biology 20 31286171
2023 Rhodopsin-mediated nutrient uptake by cultivated photoheterotrophic Verrucomicrobiota. The ISME journal 17 37120702
2023 Mechanism of Activation of the Visual Receptor Rhodopsin. Annual review of biophysics 16 37159291
2015 Characterizing rhodopsin signaling by EPR spectroscopy: from structure to dynamics. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 11 26140679
2021 Supramolecular organization of rhodopsin in rod photoreceptor cell membranes. Pflugers Archiv : European journal of physiology 10 33591421
2002 Recoverin and rhodopsin kinase. Advances in experimental medicine and biology 10 12596917
1997 High levels of rhodopsin phosphorylation in missense mutations of C-terminal region of rhodopsin. FEBS letters 9 9303550
2022 Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa. Advances in experimental medicine and biology 7 34962636
1999 Calcium-dependent regulation of rhodopsin phosphorylation. Novartis Foundation symposium 7 10614053
2024 Hidden water's influence on rhodopsin activation. Biophysical journal 6 39550612
2022 Rhodopsin-Based Optogenetics: Basics and Applications. Methods in molecular biology (Clifton, N.J.) 6 35857223
2022 Arrestin Facilitates Rhodopsin Dephosphorylation in Vivo. The Journal of neuroscience : the official journal of the Society for Neuroscience 5 35332081
2022 Gene Therapy for Rhodopsin Mutations. Cold Spring Harbor perspectives in medicine 4 35940643
2023 Lysine Ubiquitylation Drives Rhodopsin Protein Turnover. Advances in experimental medicine and biology 2 37440077
2026 Rhodopsin: The hydrogen atom of membrane biophysics. Biophysical journal 1 41540734
2025 Aggregation of the Constitutively Active K296E Rhodopsin Mutant Contributes to Retinal Degeneration. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1 40667763

Missed literature

Know a paper Affinage missed for RHO? Flag it for the maintainers and the community.

No submissions yet.